Search

everythinglearnresearchcommunity

for

Search:↓

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

A specific gene change is linked to severe hair loss.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

Certain immune cells, when activated by specific signals, can encourage hair growth.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

The Itpr3 gene causes a specific hair pattern in mice.

Apremilast did not work for treating severe alopecia areata.

CO2 fractional laser treatment helped regrow hair in a 13-year-old with alopecia areata.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

Lokivetmab reduced itching in a dog with skin lymphoma.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Erianin may effectively treat alopecia areata by targeting the immune system.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Dual TCR Treg cells are common in mouse tissues and vary by location.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.